Jmir Cancer
Overview
Jmir Cancer is a scientific journal, published by JMIR Publications since 2015 in English. The journal's country of origin is Canada and its primary focus area is oncology.
Details
Details
Abbr.
JMIR Cancer
Publisher
JMIR Publications
Start
2015
End
Continuing
Frequency
Semiannual
e-ISSN
2369-1999
Country
Canada
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 11552
24
SJR / Ranks: 5368
790
CiteScore / Ranks: 7633
3.50
Recent Articles
1.
Lin S, Duan L, Xu X, Cao H, Lu X, Wen X, et al.
JMIR Cancer
. 2025 Mar;
11:e57414.
PMID: 40085845
Background: Cancers of the bladder, kidney, and prostate are the 3 major genitourinary cancers that significantly contribute to the global burden of disease (GBD) and continue to show increasing rates...
2.
Song G, Zhang C, Bai Z, Li R, Cheng M
JMIR Cancer
. 2025 Mar;
11:e65820.
PMID: 40072918
Background: The relationship between assisted reproductive technology (ART) and childhood cancer risk has been widely debated. Previous meta-analyses did not adequately account for the impact of infertility, and this study...
3.
Zippi Z, Cortopassi I, Grage R, Johnson E, McCann M, Mergo P, et al.
JMIR Cancer
. 2025 Mar;
11:e53328.
PMID: 40068175
Background: The noninvasive imaging examinations of mammography (MG), low-dose computed tomography (CT) for lung cancer screening (LCS), and CT colonography (CTC) play important roles in screening for the most common...
4.
Spotnitz M, Giannini J, Ostchega Y, Goff S, Anandan L, Clark E, et al.
JMIR Cancer
. 2025 Mar;
11:e59298.
PMID: 40068169
Background: Breast cancer is prevalent among females in the United States. Nonmetastatic disease is treated by partial or complete mastectomy procedures. However, the rates of those procedures vary across practices....
5.
Yanagisawa Y, Watabe S, Yokoyama S, Sayama K, Kizaki H, Tsuchiya M, et al.
JMIR Cancer
. 2025 Mar;
11:e69663.
PMID: 40068144
Background: Androgen receptor axis-targeting reagents (ARATs) have become key drugs for patients with castration-resistant prostate cancer (CRPC). ARATs are taken long term in outpatient settings, and effective adverse event (AE)...
6.
Crafoord M, Ekstrand J, Sundberg K, Nilsson M, Fjell M, Langius-Eklof A
JMIR Cancer
. 2025 Mar;
11:e53539.
PMID: 40067346
Background: Digital interventions for supportive care during cancer treatment incorporating electronic patient-reported outcomes (ePROs) can enhance early detection of symptoms and facilitate timely symptom management. However, economic evaluations are needed....
7.
Mushcab H, Al Ramis M, AlRujaib A, Eskandarani R, Sunbul T, AlOtaibi A, et al.
JMIR Cancer
. 2025 Mar;
PMID: 40065600
Background: Artificial intelligence (AI) is a revolutionary upcoming tool yet to be fully integrated into several healthcare sectors, including medical imaging. AI can transform how medical imaging is conducted and...
8.
Pozzar R, Tulsky J, Berry D, Batista J, Barwick P, Lindvall C, et al.
JMIR Cancer
. 2025 Mar;
11:e66801.
PMID: 40063817
Background: People with advanced ovarian cancer and their caregivers report unmet supportive care needs. We developed a Collaborative Agenda-Setting Intervention (CASI) to elicit patients' and caregivers' needs through the patient...
9.
Johnson A, Longfellow G, Lee C, Ormseth B, Skolnick G, Politi M, et al.
JMIR Cancer
. 2025 Mar;
11:e64724.
PMID: 40053770
Background: Decision aids improve patient and clinician decision-making but are underused and often restricted to clinical settings. Objective: Given limited studies analyzing the feasibility of disseminating decision aids through social...
10.
Lyhne J, Smith A, Carstensen T, Beatty L, Bamgboje-Ayodele A, Klein B, et al.
JMIR Cancer
. 2025 Mar;
11:e63486.
PMID: 40042999
Therapist-guided eHealth interventions have been shown to engage users more effectively and achieve better outcomes than self-guided interventions when addressing psychological symptoms. Building on this evidence, this viewpoint aimed to...